BusinessCorporate FinanceMedicine looks a healthy bet

Medicine looks a healthy bet

The last year should be remembered for a few discrete recoveries within the corporate finance market. Very few sectors made a dramatic turnaround, while so many others seemed to make little or no progress at all.

The IT and biotech sectors particularly stood out for their turnaround story, as shares rallied and confidence returned to the sectors. A survey of mid-market venture capitalists and brokers for Grant Thornton tipped business services, healthcare, financial services and the retail and leisure sector for recovery over the coming months.

But sentiment elsewhere remains subdued indicating that 2004 could well be another year of uneven recovery.

It may be that, in some areas, the steep valuations reached in the last bull market did not correct themselves sufficiently when the downturn came. The tech and biotech bust was savage, leaving little room for even the most efficient to survive.

This could explain why brokers surveyed are still cautious about prospects in media and food despite developments that, in theory, should support the sector.

The Communications Act, which came into force last summer, removed most rules relating to cross-media ownership. It would be logical to expect this measure to help stimulate activity in the market.

Likewise, in the food sector, pricing pressure and the desire by larger retailers to control the supply chain should drive consolidation among smaller producers.

Elsewhere, the impending relaxation of the UK’s gambling laws in 2004 make betting chains and casino operators an obvious area for growth and deal activity.

But in the long-term, brokers recognise healthcare as being one of the safest bets. Thanks to an ageing population and insatiable demand for better drugs there will always be plenty of pressure on the government to spend on the nation’s health.

It was the healthcare sector that propelled the UK to command its strong lead in European venture capital funds in recent months.

Brokers are not just expecting recovery to be confined to drugs companies.

Tipped for particularly healthy investment are medical device manufacturing, care homes and private hospitals.

Related Articles

Grant Thornton recruits new corporate finance partner

Accounting Firms Grant Thornton recruits new corporate finance partner

10m Emma Smith, Managing Editor
Total fraud value at £2bn five-year high, finds BDO

Accounting Firms Total fraud value at £2bn five-year high, finds BDO

11m Stephanie Wix, Writer
MHA MacIntyre Hudson appoints corporate finance director

Accounting Firms MHA MacIntyre Hudson appoints corporate finance director

11m Stephanie Wix, Writer
Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

Consulting Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

11m Stephanie Wix, Writer
KPMG announces senior partner promotion in Newcastle

Accounting Firms KPMG announces senior partner promotion in Newcastle

11m Stephanie Wix, Writer
Independent city firm reports 70% growth

Accounting Firms Independent city firm reports 70% growth

11m Stephanie Wix, Writer
Tax avoidance crackdown sees 80% jump in additional HMRC revenue

Accounting Firms Tax avoidance crackdown sees 80% jump in additional HMRC revenue

11m Stephanie Wix, Writer
Making Tax Digital: the "unexpected item in the bagging area"

Accounting Standards Making Tax Digital: the "unexpected item in the bagging area"

11m Stephanie Wix, Writer